Elicio Therapeutics, Inc. (ELTX) Revenue 2020–2022
Elicio Therapeutics, Inc. (ELTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.3MFY2022 · since FY2020: $2.9M → $2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $2.3M | -91.9% |
| FY2021 | $28.3M | +883.1% |
| FY2020 | $2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTX financial trends
ELTX Net incomeELTX Net marginELTX Gross profitELTX Gross marginELTX Operating incomeELTX Operating marginELTX Operating cash flowELTX Free cash flowELTX Capital expendituresELTX Return on equityELTX Stock buybacksELTX Dividends paidELTX Total assetsELTX Total liabilitiesELTX Shareholders’ equityELTX overview →